Echinacoside is a group of natural compounds extracted from medicinal plants Cistanche and Echinacea, which has neuroprotective, antiaging, immunomodulatory and anticancer effects, but its specific role and mechanism in
tumor remains partially unclear. To our knowledge, it was the first time to reported the effect of
Echinacoside in
ovarian cancer. Colony formation, TUNEL staining, Transwell and tube formation assays were conducted to analyze the proliferation, apoptosis, invasion and tube formation abilities of serous ovarian
carcinoma cells (SKOV3 and OVCAR-3), respectively. The expressions of apoptosis-, invasion- and PI3K/AKT pathway-related
proteins were measured by western blotting. In addition, PI3K agonist (740Y-P) was used to assess the regulatory effect of
Echinacoside on PI3K/AKT signaling in
ovarian cancer. Finally, the anti-
tumor effect of
Echinacoside on SKOV3-xenografted mice was evaluated by xenograft
tumor mouse model. Our results demonstrated
Echinacoside concentration-dependently reduced the proliferation, migration and angiogenesis of
ovarian cancer cells, whereas promoted apoptosis. Moreover, western blotting revealed that
Echinacoside suppressed the growth of
ovarian cancer cells by downregulating the phosphorylation levels of PI3K, AKT and mTOR, which could be partially reversed by
740Y-P. Further, in vivo results showed that
Echinacoside could effectively alleviate the
tumor growth of xenograft mice, accompanied by the decrease of PI3K/AKT signaling. In general, our results demonstrate that
Echinacoside could reduce the
ovarian cancer progression through inhibition of PI3K/AKT pathway, suggesting that
Echinacoside may be a new treatment option for
ovarian cancer.